Glover Stephen C. Insider Trades

Insider Trading History

Track insider trading activity for Glover Stephen C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $59.3k 54,876 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.8k 54,876 shares
$0.98
$1.08
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Chief Executive Officer
Holding Value $23.3k 136,900 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.8k 136,900 shares
$0.59
$0.17
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $2.85M 136,900 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 136,900 shares
$20.80
$20.80
Larkspur Health Acquisition
Larkspur Health Acquisition LSPR
Chief Executive Officer
Holding Value $3.08M 136,900 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.08M 136,900 shares
$22.50
$22.50
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $24.5k 22,700 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.7k 22,700 shares
$1.75
$1.08
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $85.2k 78,851 shares
Last Trade
Feb 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.1k 30,122 shares
$1.33
$1.08
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $9.72k 9,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.7k 9,000 shares
$2.86
$1.08
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $9.72k 9,000 shares
Last Trade
Jul 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 9,000 shares
$5.13
$1.08
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $2.38M 85,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$547k 40,000 shares
$13.68
$28.00
Larkspur Health Acquisition
Larkspur Health Acquisition LSPR
Chief Executive Officer
Holding Value $36.6k 1,627 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.6k 1,627 shares
$22.50
$22.50
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Chief Executive Officer
Holding Value $277 1,627 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 1,627 shares
$152.46
$0.17
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $33.8k 1,627 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 1,627 shares
$20.80
$20.80
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $5.88M 210,000 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.89M 210,000 shares
$13.77
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $490k 17,500 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 17,500 shares
$13.77
$28.00
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Chief Executive Officer
Holding Value $76.3k 448,909 shares
Last Trade
Dec 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up